Sooma Medical, a Helsinki, Finland-based provider of effective brain stimulation treatments for psychiatric and neurological disorders, raised €5M in funding.
The round was led by Voima Ventures.
The company intends to use the funds to accelerate its product development and continue its rapid expansion into new and existing markets.
Led by CEO Tuomas Neuvonen, Sooma is a medical device company specializing in non-invasive brain stimulation devices for neurological and psychiatric disorders, which works closely with medical experts to develop effective treatment solutions. Its devices adhere to strict ISO 13485 and MDSAP quality management standards.
Sooma’s depression therapy is available in more than 35 countries worldwide. To date, more than 20,000 patients have used these treatments.
Commenting on the news, Tuomas Neuvonen said: “Everyone battling depression deserves a chance at a brighter tomorrow. Our innovative, drug-free treatment is designed to be easily accessible from the comfort of your own home. We are dedicated to reaching especially those underserved by medication, or those with limited access to psychotherapy, ensuring everyone suffering from depression has access to the best possible care.”
FinSMEs
12/03/2024